These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 29106029)

  • 21. Characterization of episodes of irritable bowel syndrome using ecological momentary assessment.
    Weinland SR; Morris CB; Hu Y; Leserman J; Bangdiwala SI; Drossman DA
    Am J Gastroenterol; 2011 Oct; 106(10):1813-20. PubMed ID: 21647206
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Short Health Scale: A Simple, Valid, Reliable, and Responsive Way of Measuring Subjective Health in Patients With Irritable Bowel Syndrome.
    Krarup AL; Peterson E; Ringström G; Törnblom H; Hjortswang H; Simrén M
    J Clin Gastroenterol; 2015 Aug; 49(7):565-70. PubMed ID: 25216385
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Patients suspected of irritable bowel syndrome--cross-sectional study exploring the sensitivity of Rome III criteria in primary care.
    Engsbro AL; Begtrup LM; Kjeldsen J; Larsen PV; de Muckadell OS; Jarbøl DE; Bytzer P
    Am J Gastroenterol; 2013 Jun; 108(6):972-80. PubMed ID: 23419383
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A cross-cultural investigation of attachment style, catastrophizing, negative pain beliefs, and symptom severity in irritable bowel syndrome.
    Gerson CD; Gerson MJ; Chang L; Corazziari ES; Dumitrascu D; Ghoshal UC; Porcelli P; Schmulson M; Wang WA; Zali M
    Neurogastroenterol Motil; 2015 Apr; 27(4):490-500. PubMed ID: 25817055
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An irritable bowel syndrome-specific symptom questionnaire: development and validation.
    Wiklund IK; Fullerton S; Hawkey CJ; Jones RH; Longstreth GF; Mayer EA; Peacock RA; Wilson IK; Naesdal J
    Scand J Gastroenterol; 2003 Sep; 38(9):947-54. PubMed ID: 14531531
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gastrointestinal symptoms related to the irritable bowel syndrome - a longitudinal population-based register study.
    Heinsvig Poulsen C; Falgaard Eplov L; Hjorthøj C; Eliasen M; Frost Ebstrup J; Skovbjerg S; Schröder A; Jørgensen T
    Scand J Gastroenterol; 2016; 51(4):420-6. PubMed ID: 26635123
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mixture model analysis identifies irritable bowel syndrome subgroups characterised by specific profiles of gastrointestinal, extraintestinal somatic and psychological symptoms.
    Polster A; Van Oudenhove L; Jones M; Öhman L; Törnblom H; Simrén M
    Aliment Pharmacol Ther; 2017 Sep; 46(5):529-539. PubMed ID: 28671338
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development and validation of the irritable bowel syndrome satisfaction with care scale.
    Dorn SD; Morris CB; Schneck SE; Hopper TM; Hu YJ; Kelapure R; Weinland SR; Norton WF; Norton NJ; Drossman DA
    Clin Gastroenterol Hepatol; 2011 Dec; 9(12):1065-71.e1-2. PubMed ID: 21854738
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development and testing of candidate items for inclusion in a new rheumatoid arthritis stiffness patient-reported outcome measure.
    Halls S; Dures E; Kirwan JR; Pollock J; Baker G; Edmunds A; Hewlett S
    Rheumatology (Oxford); 2018 Feb; 57(2):263-272. PubMed ID: 28407140
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Overlapping upper and lower gastrointestinal symptoms in irritable bowel syndrome patients with constipation or diarrhea.
    Talley NJ; Dennis EH; Schettler-Duncan VA; Lacy BE; Olden KW; Crowell MD
    Am J Gastroenterol; 2003 Nov; 98(11):2454-9. PubMed ID: 14638348
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fecal incontinence in irritable bowel syndrome: Prevalence and associated factors in Swedish and American patients.
    Simrén M; Palsson OS; Heymen S; Bajor A; Törnblom H; Whitehead WE
    Neurogastroenterol Motil; 2017 Feb; 29(2):. PubMed ID: 27581702
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Follow-up of patients with functional bowel symptoms treated with a low FODMAP diet.
    Maagaard L; Ankersen DV; Végh Z; Burisch J; Jensen L; Pedersen N; Munkholm P
    World J Gastroenterol; 2016 Apr; 22(15):4009-19. PubMed ID: 27099444
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The central role of gastrointestinal-specific anxiety in irritable bowel syndrome: further validation of the visceral sensitivity index.
    Labus JS; Mayer EA; Chang L; Bolus R; Naliboff BD
    Psychosom Med; 2007 Jan; 69(1):89-98. PubMed ID: 17244851
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development of the Pulmonary Arterial Hypertension-Symptoms and Impact (PAH-SYMPACT®) questionnaire: a new patient-reported outcome instrument for PAH.
    McCollister D; Shaffer S; Badesch DB; Filusch A; Hunsche E; Schüler R; Wiklund I; Peacock A;
    Respir Res; 2016 Jun; 17(1):72. PubMed ID: 27301413
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cultural adaptation: translatability assessment and linguistic validation of the patient-reported outcome instrument for irritable bowel syndrome with diarrhea.
    Delgado-Herrera L; Lasch K; Popielnicki A; Nishida A; Arbuckle R; Banderas B; Zentner S; Gagainis I; Zeiher B
    Patient Relat Outcome Meas; 2016; 7():81-92. PubMed ID: 27382346
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Coping Skills Are Associated With Gastrointestinal Symptom Severity and Somatization in Patients With Irritable Bowel Syndrome.
    Wilpart K; Törnblom H; Svedlund J; Tack JF; Simrén M; Van Oudenhove L
    Clin Gastroenterol Hepatol; 2017 Oct; 15(10):1565-1571.e3. PubMed ID: 28286196
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of intragastric FODMAP infusion on upper gastrointestinal motility, gastrointestinal, and psychological symptoms in irritable bowel syndrome vs healthy controls.
    Masuy I; Van Oudenhove L; Tack J; Biesiekierski JR
    Neurogastroenterol Motil; 2018 Jan; 30(1):. PubMed ID: 28762592
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analyzing the content of outcome measures in clinical trials on irritable bowel syndrome using the international classification of functioning, disability and health as a reference.
    Schönrich S; Brockow T; Franke T; Dembski R; Resch KL; Cieza A
    Rehabilitation (Stuttg); 2006 Jun; 45(3):172-80. PubMed ID: 16755436
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cultural adaptation and application of the IBS-QOL in China: a disease-specific quality-of-life questionnaire.
    Huang WW; Zhou FS; Bushnell DM; Diakite C; Yang XH
    Qual Life Res; 2007 Aug; 16(6):991-6. PubMed ID: 17440830
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Histamine Receptor H1-Mediated Sensitization of TRPV1 Mediates Visceral Hypersensitivity and Symptoms in Patients With Irritable Bowel Syndrome.
    Wouters MM; Balemans D; Van Wanrooy S; Dooley J; Cibert-Goton V; Alpizar YA; Valdez-Morales EE; Nasser Y; Van Veldhoven PP; Vanbrabant W; Van der Merwe S; Mols R; Ghesquière B; Cirillo C; Kortekaas I; Carmeliet P; Peetermans WE; Vermeire S; Rutgeerts P; Augustijns P; Hellings PW; Belmans A; Vanner S; Bulmer DC; Talavera K; Vanden Berghe P; Liston A; Boeckxstaens GE
    Gastroenterology; 2016 Apr; 150(4):875-87.e9. PubMed ID: 26752109
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.